IL-23R

IL-23R

IL-23R 詳細

Molecule Name
Interleukin 23 Receptor
分子の別称
IL-23 R,IL-23 Receptor
Drug Development Progress
治験薬の数2
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
IL-23 receptor,IL23R,Interleukin 23 Receptor,Interleukin-23 Receptor,IL-23R
バックグランド
Interleukin 23 receptor (IL-23R) is a type I cytokine receptor, and IL-23R pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. Also, IL-23R associates constitutively with Janus kinase 2 (JAK2), and binds to transcription activator STAT3 in a ligand-dependent manner. Furthermore, IL-23R mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. As for IL-23, it may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis.

お問い合わせ

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BezisterimHE-3286; NE-3107Phase 3 ClinicalHarbor Therapeutics Inc
Alzheimer Disease; Arthritis, Rheumatoid; Brain Injuries, Traumatic; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Insulin Resistance; Parkinson Disease; Post-Acute COVID-19 Syndrome
詳細
PN-232PN-232; JNJ75105186Phase 1 ClinicalProtagonist Therapeutics Inc
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
IcotrokinraPN-235; JNJ-2113; JNJ-77242113-AAC; PN-21235; JNJ-77242113ApprovedProtagonist Therapeutics IncICOTYDEUnited StatesPlaque psoriasisJanssen Biotech Inc2026-03-17
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Erythrodermic psoriasis; Generalised pustular psoriasis; Plaque psoriasis; Psoriasis
詳細